Abstract:Rationale and Objectives Radiomics has demonstrated potential in predicting the cytogenetic status of multiple myeloma (MM). However, the role of single-sequence radiomic nomograms in predicting the high-risk cytogenetic (HRC) status of MM remains underexplored. This study aims to develop and validate radiomic nomograms based on fat-suppressed T2-weighted images (T2WI-FS) for predicting MM’s HRC status, facilitating pre-treatment decision-making and prognostic assessment. Materials and methods A cohort of 159 MM patients was included, comprising 71 HRC and 88 non-HRC cases. Regions of interest within the most significant tumor lesions on T2WI-FS images were manually delineated, yielding 1688 features. Fourteen radiomic features were selected using 10-fold cross-validation, employing methods such as variance thresholds, Student’s t-test, redundancy analysis, and least absolute shrinkage and selection operator (LASSO). Logistic regression was utilized to develop three prediction models: a clinical model (model 1), a T2WI-FS radiomic model (model 2), and a combined clinical-radiomic model (model 3). Receiver operating characteristic (ROC) curves evaluated and compared the diagnostic performance of these models. Kaplan-Meier survival analysis and log-rank tests assessed the prognostic value of the radiomic nomograms. Results Models 2 and 3 demonstrated significantly greater diagnostic efficacy compared to model 1 (p < 0.05). The areas under the ROC curve for models 1, 2, and 3 were as follows: training set—0.650, 0.832, and 0.846; validation set—0.702, 0.730, and 0.757, respectively. Kaplan-Meier survival analysis indicated comparable prognostic values between the radiomic nomogram and MM cytogenetic status, with log-rank test results (p < 0.05) and concordance indices of 0.651 and 0.659, respectively; z-score test results were not statistically significant (p = 0.153). Additionally, Kaplan-Meier analysis revealed that patients in the non-HRC group low-RS group, and aged ≤ 60 years exhibited the longest overall survival, while those in the HRC group, high-RS group, and aged > 60 years demonstrated the shortest overall survival (p = 0.004, Log-rank test). Conclusions Radiomic nomograms are capable of predicting the HRC status in MM. The cytogenetic status, radiomics model Rad score, and age collectively influence the overall survival of MM patients. These factors potentially contribute to pre-treatment clinical decision-making and prognostic assessment.

The Potential Role of MRI-based Bone Marrow Radiomics in Survival Prediction of Newly Diagnosed Multiple Myeloma

MRI-Based Bone Marrow Radiomics Nomogram for Prediction of Overall Survival in Patients With Multiple Myeloma

MRI-based bone marrow radiomics for predicting cytogenetic abnormalities in multiple myeloma

Recent advances in imaging and artificial intelligence (AI) for quantitative assessment of multiple myeloma

Radiomic Nomogram for Predicting High-Risk Cytogenetic Status in Multiple Myeloma Based on Fat-Suppressed T2-weighted Magnetic Resonance Imaging

Prediction of High-Risk Cytogenetic Status in Multiple Myeloma Based on Magnetic Resonance Imaging: Utility of Radiomics and Comparison of Machine Learning Methods

Radiomics Models Based on Magnetic Resonance Imaging for Prediction of the Response to Bortezomib-Based Therapy in Patients with Multiple Myeloma

Identification Of Potential Prognostic Biomarker For Predicting Survival In Multiple Myeloma Using Bioinformatics Analysis And Experiments

18F‑FDG PET/CT Based Radiomics Features Improve Prediction of Prognosis: Multiple Machine Learning Algorithms and Multimodality Applications for Multiple Myeloma

Predicting Survival Duration With MRI Radiomics of Brain Metastases From Non-small Cell Lung Cancer

Role of Imaging in Multiple Myeloma: A Potential Opportunity for Quantitative Imaging and Radiomics?

Magnetic resonance imaging-based nomograms predict high-risk cytogenetic abnormalities in multiple myeloma: a two-center study

Radiomics and artificial intelligence analysis of CT data for the identification of prognostic features in multiple myeloma

Machine Learning Model Based on Optimized Radiomics Feature from 18F-FDG-PET/CT and Clinical Characteristics Predicts Prognosis of Multiple Myeloma: A Preliminary Study

MiRNAs with Prognostic Significance in Multiple Myeloma

Correlation analysis of laboratory indicators, genetic abnormalities and staging in patients with newly diagnosed multiple myeloma

[Prognosis and immune biomarkers of multiple myeloma]

Discriminating Minimal Residual Disease Status in Multiple Myeloma Based on MRI: Utility of Radiomics and Comparison of Machine-Learning Methods.

Potential of radiomics analysis and machine learning for predicting brain metastasis in newly diagnosed lung cancer patients

The quantitative parameters based on marrow metabolism derived from synthetic MRI: A pilot study of prognostic value in participants with newly diagnosed multiple myeloma

A Preliminary Study Using Spinal MRI-based Radiomics to Predict High-Risk Cytogenetic Abnormalities in Multiple Myeloma.